# Changes in Retinal Function After Intravitreal Ranibizumab for Age-related Macular Degeneration

> **NCT00539734** · NA · COMPLETED · sponsor: **Prince of Songkla University** · enrollment: 25 (actual)

## Conditions studied

- Age-related Macular Degeneration

## Interventions

- **DRUG:** ranibizumab

## Key facts

- **NCT ID:** NCT00539734
- **Lead sponsor:** Prince of Songkla University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-08
- **Primary completion:** 2008-12
- **Final completion:** 2009-02
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2011-04-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00539734

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00539734, "Changes in Retinal Function After Intravitreal Ranibizumab for Age-related Macular Degeneration". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00539734. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*